<p>A, Schematic representation for the synthesis of imidazole based small molecules. B, Breast cancer cells (2.5 X 10<sup>4</sup>/mL, MCF-7 & MDA-MB-231) were plated in triplicate, treated with indicated concentrations (0, 10, 25 and 50 μM) of CIP, and then subjected to MTT assay after 24, 48 and 72 h to analyse proliferation of cells. CIP suppresses the viability of various breast cancer cell lines in a dose- and time-dependent manner.</p
